{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T19:08:18Z","timestamp":1780945698709,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2018ZX10101003-005-008"],"award-info":[{"award-number":["2018ZX10101003-005-008"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.virol.2021.01.009","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T08:35:02Z","timestamp":1611304502000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A human bispecific neutralization antibody against four serotypes of dengue virus"],"prefix":"10.1016","volume":"558","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1515-2683","authenticated-orcid":false,"given":"Rong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5124-9688","authenticated-orcid":false,"given":"Yunzhou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2021.01.009_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/0929866526666190311163820","article-title":"Bispecific antibody (bsAb) construct formats and their application in cancer therapy","volume":"26","author":"Acheampong","year":"2019","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.virol.2021.01.009_bib2","doi-asserted-by":"crossref","first-page":"E367","DOI":"10.3390\/v12040367","article-title":"Structure-based design of antivirals against envelope glycoprotein of dengue virus","volume":"12","author":"Anasir","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2021.01.009_bib3","first-page":"1","article-title":"Development and clinical application of bispecific antibody in the treatment of colorectal cancer","author":"Balibegloo","year":"2020","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.virol.2021.01.009_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2021.01.009_bib5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.virol.2021.01.009_bib6","first-page":"351","article-title":"[Pathophysiological mechanisms of dengue fever: critical review of current concepts]","volume":"69","author":"Deparis","year":"2009","journal-title":"Med. Trop."},{"key":"10.1016\/j.virol.2021.01.009_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.aaa8651","article-title":"DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers","volume":"349","author":"Fibriansah","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.virol.2021.01.009_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jviromet.2015.04.004","article-title":"Production and characterization of monospecific and bispecific antibodies against dengue virus NS1 protein","volume":"220","author":"Ganguly","year":"2015","journal-title":"J Virol Methods"},{"key":"10.1016\/j.virol.2021.01.009_bib9","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1073\/pnas.0703498104","article-title":"Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention","volume":"104","author":"Goncalvez","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2021.01.009_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/erv.09.139","article-title":"Domain III of the envelope protein as a dengue vaccine target","volume":"9","author":"Guzman","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2021.01.009_bib11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/265739a0","article-title":"Antibody-enhanced dengue virus infection in primate leukocytes","volume":"265","author":"Halstead","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.virol.2021.01.009_bib12","doi-asserted-by":"crossref","first-page":"E829","DOI":"10.3390\/v12080829","article-title":"Dengue: a minireview","volume":"12","author":"Harapan","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2021.01.009_bib13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/13543776.2019.1637422","article-title":"Cancer immunotherapy using anti-TIM3\/PD-1 bispecific antibody: a patent evaluation of EP3356411A1","volume":"29","author":"Herrera-Camacho","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.virol.2021.01.009_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV","volume":"449","author":"Hessell","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.virol.2021.01.009_bib15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3389\/fimmu.2018.00597","article-title":"Modulation of dengue\/zika virus pathogenicity by antibody-dependent enhancement and strategies to protect against enhancement in zika virus infection","volume":"9","author":"Khandia","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2021.01.009_bib16","first-page":"152","article-title":"Neutralizing antibody response and efficacy of novel recombinant tetravalent dengue DNA vaccine comprising envelope domain III in mice","volume":"42","author":"Kulkarni","year":"2017","journal-title":"Iran. J. Med. Sci."},{"key":"10.1016\/j.virol.2021.01.009_bib17","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4161\/mabs.26436","article-title":"Effects of altered FcgammaR binding on antibody pharmacokinetics in cynomolgus monkeys","volume":"5","author":"Leabman","year":"2013","journal-title":"mAbs"},{"key":"10.1016\/j.virol.2021.01.009_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.str.2017.11.017","article-title":"Structural and functional characterization of a cross-reactive dengue virus neutralizing antibody that recognizes a cryptic epitope","volume":"26","author":"Li","year":"2018","journal-title":"Structure"},{"key":"10.1016\/j.virol.2021.01.009_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41423-020-0417-8","article-title":"Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics","volume":"17","author":"Li","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.virol.2021.01.009_bib20","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3389\/fmicb.2018.01214","article-title":"Potent neutralization ability of a human monoclonal antibody against serotype 1 dengue virus","volume":"9","author":"Lu","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2021.01.009_bib21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/PEC.0b013e31828ed30e","article-title":"A review of dengue fever: a resurging tropical disease","volume":"29","author":"Mangold","year":"2013","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.virol.2021.01.009_bib22","doi-asserted-by":"crossref","DOI":"10.2174\/1389557520666200804115045","article-title":"Review on dengue virus fusion\/entry process and their inhibition by small bioactive molecules","author":"Naresh","year":"2020","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.virol.2021.01.009_bib23","doi-asserted-by":"crossref","first-page":"696","DOI":"10.47102\/annals-acadmedsg.V42N12p696","article-title":"Challenges of dengue control","volume":"42","author":"Ng","year":"2013","journal-title":"Ann. Acad. Med. Singapore"},{"key":"10.1016\/j.virol.2021.01.009_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002581","article-title":"Dengue virus in sub-tropical northern and central Viet Nam: population immunity and climate shape patterns of viral invasion and maintenance","volume":"7","author":"Rabaa","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virol.2021.01.009_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/497443a","article-title":"Dengue virus: two hosts, two structures","volume":"497","author":"Rey","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.virol.2021.01.009_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002194","article-title":"Review of Dengue hemorrhagic fever fatal cases seen among adults: a retrospective study","volume":"7","author":"Sam","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virol.2021.01.009_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmii.2020.03.007","article-title":"Dengue hemorrhagic fever - a systemic literature review of current perspectives on pathogenesis, prevention and control","author":"Wang","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.virol.2021.01.009_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/14760584.2015.961431","article-title":"Dengue virus envelope protein domain I\/II hinge: a key target for dengue virus vaccine design?","volume":"14","author":"Widman","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2021.01.009_bib29","doi-asserted-by":"crossref","first-page":"43331","DOI":"10.1074\/jbc.M112.397869","article-title":"LUZ-Y, a novel platform for the mammalian cell production of full-length IgG-bispecific antibodies","volume":"287","author":"Wranik","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2021.01.009_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-015-0195-4","article-title":"Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19\/CD3 for refractory acute lymphoid leukemia","volume":"8","author":"Wu","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.virol.2021.01.009_bib31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/1568026616666160829155327","article-title":"Structure and function of the non-structural protein of dengue virus and its applications in antiviral therapy","volume":"17","author":"Xie","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.virol.2021.01.009_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41541-016-0003-3","article-title":"A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus","volume":"2","author":"Xu","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.virol.2021.01.009_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nsmb.2463","article-title":"Cryo-EM structure of the mature dengue virus at 3.5-A resolution","volume":"20","author":"Zhang","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virol.2021.01.009_bib34","doi-asserted-by":"crossref","first-page":"197882","DOI":"10.1016\/j.virusres.2020.197882","article-title":"Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model","volume":"278","author":"Zhou","year":"2020","journal-title":"Virus Res."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682221000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682221000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:54:13Z","timestamp":1758588853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682221000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":34,"alternative-id":["S0042682221000179"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2021.01.009","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A human bispecific neutralization antibody against four serotypes of dengue virus","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2021.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}